This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.

If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.
AcceptDecline
Close
Thought Leadership

Presentation: Key Considerations for Pharma Developing a Digital Therapeutic

March 8, 2022

This video features Biofourmis Chief Operating Officer Jaydev Thakkar's presentation at DTx West 2022, covering Key Considerations for Pharma Developing a Digital Therapeutic.Biofourmis is pioneering a new category of medicine by developing clinically-validated, software-based therapeutics to treat and manage patients with unmet clinical needs. These digital therapeutics work independently or in conjunction with pharmacotherapies - augmenting drug efficacy, reducing costs and driving better patient outcomes.

Pharmaceutical companies prescribe digital therapeutics as a companion therapy with high-value drugs to improve efficacy and to better manage and treat patients with complex chronic conditions.